ATE315584T1 - Monoklonale antikörper gegen recombinantes stratum corneum chymotryptisches enzym (scce) - Google Patents

Monoklonale antikörper gegen recombinantes stratum corneum chymotryptisches enzym (scce)

Info

Publication number
ATE315584T1
ATE315584T1 AT03078393T AT03078393T ATE315584T1 AT E315584 T1 ATE315584 T1 AT E315584T1 AT 03078393 T AT03078393 T AT 03078393T AT 03078393 T AT03078393 T AT 03078393T AT E315584 T1 ATE315584 T1 AT E315584T1
Authority
AT
Austria
Prior art keywords
scce
stratum corneum
monoclonal antibodies
antibodies against
chymotryptic enzyme
Prior art date
Application number
AT03078393T
Other languages
English (en)
Inventor
Egelrud Thorbjoern
Lennart Hansson
Original Assignee
Egelrud Thorbjoern
Lennart Hansson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egelrud Thorbjoern, Lennart Hansson filed Critical Egelrud Thorbjoern
Application granted granted Critical
Publication of ATE315584T1 publication Critical patent/ATE315584T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03078393T 1993-06-18 1994-06-20 Monoklonale antikörper gegen recombinantes stratum corneum chymotryptisches enzym (scce) ATE315584T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93725A DK72593D0 (da) 1993-06-18 1993-06-18 Rekombinant protein

Publications (1)

Publication Number Publication Date
ATE315584T1 true ATE315584T1 (de) 2006-02-15

Family

ID=8096824

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94917764T ATE252884T1 (de) 1993-06-18 1994-06-20 Rekombinantes stratum corneum chymotypisches enzym ( scce)
AT03078393T ATE315584T1 (de) 1993-06-18 1994-06-20 Monoklonale antikörper gegen recombinantes stratum corneum chymotryptisches enzym (scce)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94917764T ATE252884T1 (de) 1993-06-18 1994-06-20 Rekombinantes stratum corneum chymotypisches enzym ( scce)

Country Status (21)

Country Link
US (2) US5834290A (de)
EP (2) EP1398326B1 (de)
JP (1) JP3542804B2 (de)
KR (1) KR100379207B1 (de)
CN (1) CN100457908C (de)
AT (2) ATE252884T1 (de)
AU (1) AU684518B2 (de)
BR (1) BR9407015A (de)
CA (1) CA2165197C (de)
CZ (1) CZ289600B6 (de)
DE (2) DE69434612T2 (de)
DK (3) DK72593D0 (de)
ES (2) ES2208656T3 (de)
FI (1) FI119027B (de)
HU (1) HU220339B (de)
NO (1) NO322728B1 (de)
PL (1) PL178589B1 (de)
RU (1) RU2160312C2 (de)
SK (1) SK284599B6 (de)
UA (1) UA45314C2 (de)
WO (1) WO1995000651A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
US5976556A (en) * 1996-06-13 1999-11-02 Active Organics, Inc. Combination of acid protease enzymes and acidic buffers and uses thereof
GB9616139D0 (en) * 1996-08-01 1996-09-11 Grampian Pharm Ltd Veterinary treatments
CA2280747A1 (en) * 1997-02-12 1998-11-05 Johnson & Johnson Consumer Companies, Inc. Serine protease and topical retinoid compositions
US5856139A (en) * 1997-03-11 1999-01-05 Incyte Pharmaceuticals, Inc. Proline-rich acidic protein
US6627403B2 (en) * 1997-03-19 2003-09-30 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US6294344B1 (en) * 1997-03-19 2001-09-25 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US6316213B1 (en) * 1997-03-19 2001-11-13 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian, breast and lung cancer
US5962300A (en) 1997-03-26 1999-10-05 Incyte Pharmaceuticals, Inc. Human kallikrein
FR2761363B1 (fr) * 1997-03-28 1999-11-26 Oreal Polypeptide purifie de l'epiderme et son utilisation
AU7484198A (en) * 1997-05-12 1998-12-08 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
EP0898962A1 (de) * 1997-08-28 1999-03-03 Becton, Dickinson and Company Transdermale Pflaster und Verfahren zur Inaktivierung von Hautproteasen
DE69734840D1 (de) * 1997-10-03 2006-01-12 Procter & Gamble Eine protease aus keratinocyten
US6589770B1 (en) 1997-10-03 2003-07-08 The Procter & Gamble Company Keratinocyte derived protease
US6262249B1 (en) 1998-06-23 2001-07-17 Chiron Corporation Pancreatic cancer genes
US20050053983A1 (en) * 1998-11-20 2005-03-10 Fuso Pharmaceutical Industries, Ltd. Novel serine protease BSSP4
SE9900431D0 (sv) * 1999-02-09 1999-02-09 Johan Stenflo Monoklonal antikropp
US6485957B1 (en) 1999-04-30 2002-11-26 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease EOS
US6420157B1 (en) * 1999-04-30 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Zymogen activation system
US6458564B1 (en) 1999-08-31 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease T
US6426199B1 (en) * 1999-08-31 2002-07-30 Ortho-Mcneil Pharmaceutical, Inc. Dna
KR100596595B1 (ko) * 2000-04-04 2006-07-06 칼라 액세스, 인크. 피부 지질 장벽 기능 증진용 조성물
JP4262479B2 (ja) * 2001-02-09 2009-05-13 トールビョルン・エーイェルルード Ｓｃｃｅ改変トランスジェニック哺乳動物およびヒト疾患のモデルとしてのそれらの使用
US7019194B2 (en) 2001-02-09 2006-03-28 Lennart Hansson SCCE modified transgenic mammals and their use as models of human disease
GB0128629D0 (en) * 2001-11-29 2002-01-23 Univ Sheffield Method
RU2230575C2 (ru) * 2002-06-18 2004-06-20 Закрытое акционерное общество "Петроспирт" Антисептическое средство "ахдез 3000"
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
RU2235324C1 (ru) * 2003-02-25 2004-08-27 Государственное учреждение Тверская государственная медицинская академия Способ определения казеинолитической активности микроорганизмов при экспресс-диагностике дисбактериоза кишечника
CN100518740C (zh) * 2003-06-06 2009-07-29 阿里克斯股份公司 杂环化合物作为scce抑制剂的制药用途
CA2468651A1 (en) * 2003-06-13 2004-12-13 Eleftherios P. Diamandis Detection of neurodegenerative diseases
WO2005075667A1 (en) * 2004-02-03 2005-08-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with kallikrein 7 (klk7)
WO2005085469A2 (en) * 2004-03-09 2005-09-15 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with rho-associated protein kinase 1 (rock1)
US9205080B2 (en) 2006-11-16 2015-12-08 Transderm, Inc. Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
US8476243B2 (en) 2006-12-29 2013-07-02 Transderm, Inc. Methods and compositions for treating keratin hyperproliferative disorders
FR2925312B1 (fr) * 2007-12-19 2016-12-02 Oreal Utilisation cosmetique de proteines de type desmogleine i
US8466335B2 (en) 2010-04-26 2013-06-18 The Procter & Gamble Company Personal care product
US8685309B2 (en) 2010-04-26 2014-04-01 The Procter & Gamble Company Method for making a personal care product
TWI556737B (zh) 2011-02-11 2016-11-11 陶氏農業科學公司 改良的殺蟲劑配方
US10172789B2 (en) 2013-01-24 2019-01-08 Palvella Therapeutics Llc Compositions for transdermal delivery of mTOR inhibitors
RU2585960C1 (ru) * 2015-02-17 2016-06-10 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт медицины труда" (ФГБНУ "НИИ МТ") Способ определения наследственной предрасположенности к нарушению барьерной функции кожи
WO2018129364A1 (en) 2017-01-06 2018-07-12 Palvella Therapeutics Llc Anhydrous compositions of mtor inhibitors and methods of use
US20200040103A1 (en) 2018-03-14 2020-02-06 Genentech, Inc. Anti-klk5 antibodies and methods of use
CN108421034A (zh) * 2018-04-24 2018-08-21 济南磐升生物技术有限公司 激肽释放酶7在皮肤创伤愈合中的应用
EP3802568A4 (de) * 2018-06-08 2022-07-13 The Board of Regents of the University of Oklahoma Peptidtherapeutika zur behandlung von morbus alzheimer und verwandten erkrankungen
EP3817743A4 (de) 2018-07-02 2022-07-06 Palvella Therapeutics, Inc. Wasserfreie zusammensetzungen von mtor-hemmern und verfahren zur verwendung
US12252582B2 (en) 2019-08-29 2025-03-18 University Of Delaware Biofunctional thiophene monomers and polymers thereof for electronic biomedical devices
AU2020349509A1 (en) * 2019-09-18 2022-03-31 Genentech, Inc. Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use
GB202001447D0 (en) 2020-02-03 2020-03-18 Ucb Biopharma Sprl Antibodies
BR102020009679A2 (pt) 2020-05-14 2021-11-23 Fundação Universidade Federal Do Abc - Ufabc Anticorpos recombinantes humanos para inibição da calicreína tecidual humana 7 (klk7) e uso em doenças relacionadas ao processo de descamação da pele
GB202018320D0 (en) * 2020-11-20 2021-01-06 Univ Newcastle Methods of producing recombinant complement proteins
EP4304732A1 (de) * 2021-03-12 2024-01-17 Genentech, Inc. Anti-klk7-antikörper, anti-klk5-antikörper, multispezifische anti-klk5/klk7-antikörper und verfahren zur verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
US4695458A (en) * 1986-02-05 1987-09-22 Krumeich Jorg H Solution of alpha-chymotrypsin
JP3200609B2 (ja) * 1990-12-28 2001-08-20 敏一 中村 上皮細胞増殖促進剤
GB9207288D0 (en) * 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
RU2036658C1 (ru) * 1992-07-27 1995-06-09 Тихоокеанский научно-исследовательский институт рыбного хозяйства и океанографии Способ лечения инфицированных ран
US5470733A (en) * 1993-06-01 1995-11-28 University Of Maryland Calcium free subtilisin mutants
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
AU5435496A (en) * 1995-04-04 1996-10-23 Eli Lilly And Company Amyloid precursor protein protease

Also Published As

Publication number Publication date
WO1995000651A1 (en) 1995-01-05
HU220339B (hu) 2001-12-28
DE69434612D1 (de) 2006-04-06
CA2165197C (en) 2009-02-10
NO322728B1 (no) 2006-12-04
HU9503618D0 (en) 1996-02-28
US5834290A (en) 1998-11-10
NO955110L (no) 1996-02-15
FI956075L (fi) 1996-02-16
ATE252884T1 (de) 2003-11-15
SK158695A3 (en) 1997-02-05
NO955110D0 (no) 1995-12-15
EP0703985B1 (de) 2003-10-29
JPH08511431A (ja) 1996-12-03
DK72593D0 (da) 1993-06-18
EP1398326B1 (de) 2006-01-11
PL178589B1 (pl) 2000-05-31
US5981256A (en) 1999-11-09
JP3542804B2 (ja) 2004-07-14
FI956075A0 (fi) 1995-12-18
DE69434612T2 (de) 2006-10-05
BR9407015A (pt) 1996-09-10
SK284599B6 (sk) 2005-07-01
DE69433280T2 (de) 2004-07-22
ES2208656T3 (es) 2004-06-16
KR100379207B1 (ko) 2003-09-26
UA45314C2 (uk) 2002-04-15
CA2165197A1 (en) 1995-01-05
EP1398326A2 (de) 2004-03-17
EP1398326A3 (de) 2004-03-31
CZ289600B6 (cs) 2002-03-13
CN100457908C (zh) 2009-02-04
HUT74835A (en) 1997-02-28
CZ333595A3 (en) 1997-03-12
DE69433280D1 (de) 2003-12-04
AU6935294A (en) 1995-01-17
ES2256669T3 (es) 2006-07-16
RU2160312C2 (ru) 2000-12-10
AU684518B2 (en) 1997-12-18
FI119027B (fi) 2008-06-30
PL312189A1 (en) 1996-04-01
DK0703985T3 (da) 2004-02-23
DK1398326T3 (da) 2006-05-22
CN1128047A (zh) 1996-07-31
EP0703985A1 (de) 1996-04-03

Similar Documents

Publication Publication Date Title
DE69434612D1 (de) Monoklonale Antikörper gegen recombinantes Stratum Corneum chymotryptisches Enzym (SCCE)
DE69633825D1 (de) Modifiziertes enzym mit lipolytischer aktivität
NO981353D0 (no) Regulerte gener og anvendelser derav
TR200000578T2 (tr) Heparanas aktiviteye sahip olan bir polipeptit deşifre eden polinükleotit ve çevrilmiş hücrelerde aynısını izahı.
DK0832229T3 (da) CD40L-mutein
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
NL300153I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
DE69839566D1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
AR053931A2 (es) Secuencia de adn que codifica una proteina de a. thaliana que posee actividad de delta -5,7-esterol, delta-7-reductasa, proteina delta-7red
ATE271125T1 (de) Neuartige tyrosinkinase
FI840104A7 (fi) Yhdistelmä-DNA-ekspressoimisvektoreita, jotka ovat käyttökelpoisia Bacillus- ja muissa isäntäsoluissa.
TR26073A (tr) Bacillus thuringiensis jenleri,toksinleri ve insektisid olarak kullanimlari.
ITRM930845A0 (it) Peptide ad attivita' di substrato e/o inibitore dell'enzima transglutaminasi e suo uso in giagnosi e terapia.
NO962023L (no) Endotelin-konverterende enzym
DE3855007D1 (de) METHODE ZUR REINIGUNG REKOMBINANTER t-PA VON DEN IHREN ENTSPRECHENDEN WIRTSZELLPROTEINEN
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
SE9302168D0 (sv) Ryggsaeck med ihopfaellbar sittstol

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1398326

Country of ref document: EP